MedTrace Logo

Physical Activity, Fertility, and Spontaneous Abortion in Danish Couples Trying to Conceive

NCT06705712 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 530

Last updated 2025-01-28

No results posted yet for this study

Summary

Physical activity in both the preconception period and during pregnancy may enhance the probability of getting pregnant and reduce the risks of complications during pregnancy. Adults, including pregnant women without complications, are recommended to be physically active for at least 30 minutes per day to maintain physical and mental health. Nonetheless, many women reduce their level of exercise during early pregnancy.

With this project, we will test the effectiveness of receiving motivational counseling on physical activity (PA) among women trying to conceive and during the first trimester of the pregnancy if they conceive. We will further investigate whether PA is associated with fecundability, spontaneous abortion (SAB) and other birth outcomes, i.e., gestational diabetes, preeclampsia, and birth weight.

Conditions

  • Fertility
  • Fecundability
  • Time-to-Pregnancy
  • Spontaneous Abortion
  • Pregnancy Outcome
  • Pregnancy Complications

Interventions

BEHAVIORAL

Use of activity trackers and motivational conversations to enhance focus on physical activity among women trying to conceive.

All participants will receive a wrist-worn activity tracker (Garmin VívoSmart 5) which will be connected with an application, Fitrockr. Data from the devices will be linked to data from the Snartforældre-questionnaires. The participants are asked to wear the tracker 24/7 during preconception and during the first trimester of their pregnancy if they conceive within 12 months. Participants will receive information material and be asked to set goals for their PA level. To follow-up on the goal setting, they will receive two phone calls, where the conversations will be inspired by motivational interviewing.

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Anne Sofie Dam Laursen, cand.scient, ph.d., · Department of Clinical Epidemiology, Aarhus University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06705712 on ClinicalTrials.gov